Datavant key facts
as of Oct 2026- Developer of a privacy-preserving health data collaboration platform designed to make the world's health data secure, accessible, and actionable.
- Datavant is valued at approximately $7.0B as of Oct 2026 (last reported valuation).
- It has raised $83.0M; the latest was Merger/Acquisition in Dec 2025.
- Notable investors include KittyHawk, Oxeon Partners, Town Hall Ventures, New Mountain Capital, Ardan Equity.
- Status: Privately Held (backing).
Datavant's last reported valuation, Jul 2021. Nothing priced has surfaced since.
- ·Watch Datavant: the Monday email on marks, rounds and moves
Datavant funding rounds
No funding rounds for Datavant are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Datavant
5Datavant valuation
Datavant's last reported valuation was $7 billion in Jul 2021. No priced round, secondary trade or fund mark has surfaced since.
Datavant investors
5 investors are on record for Datavant, including KittyHawk, Oxeon Partners, Town Hall Ventures and New Mountain Capital.
About Datavant
Developer of a privacy-preserving health data collaboration platform designed to make the world's health data secure, accessible, and actionable. The company's health data platform provides services including release of information, health data retrieval, and data linkage solutions, thereby enabling healthcare organizations to securely connect proprietary and real-world data for research, care, and analytics.
- Sector
- Healthcare
- HQ
- Phoenix, AZ, United States
- Employees
- 6,978
- Website
- datavant.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.